# A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants

> **NCT07652723** · PHASE1 · RECRUITING · sponsor: **Bayer** · enrollment: 16 (estimated)

## Conditions studied

- Drug-drug Interaction

## Interventions

- **DRUG:** Aspirin
- **DRUG:** BAY3389934

## Key facts

- **NCT ID:** NCT07652723
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-29
- **Primary completion:** 2026-12-29
- **Final completion:** 2026-12-29
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652723, "A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*